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Here, we investigated the eﬀect of chronic mild stress (CMS) on the development of atherosclerosis as well as the expression of
Toll-like receptors (TLRs) signaling pathway in adolescent apolipoprotein E knockout (apoE-/-) mice. Mice were subjected to
daily CMS for 0, 4, and 12 weeks, respectively. To identify the expression of Toll-like receptor 4 signaling pathway in adolescent
apolipoprotein E knockout mice subjected to CMS, we compared gene expression in aortas of stressed and unstressed mice using
TLRs signaling pathway real-time PCR microarrays consisting of 87 genes. We found that atherosclerosis lesions both in aortic
tress and sinuses of CMS mice were signiﬁcantly increased linearly in response to duration of CMS exposure. Among 87 genes
analyzed, 15 genes were upregulated in stressed mice, especially TLR4, myeloid diﬀerentiation factor 88 (MyD88), and IL-1β,a n d
28genesweredownregulatedcomparedwithnonstressedmice.CMSmicedemonstratedmarkedlyincreasedaorticatherosclerosis
that were associated with signiﬁcant increases in levels of expression of TLR4, MyD88, nuclear factor κB( N F - κB ) ,M C P - 1 ,I L - 1 β,
TNF-α, and sICAM-1. Taken together, our results suggest an important role for TLR4 signaling pathway in atherosclerosis in a
CMS mouse model.
Copyright © 2009 Hongfeng Gu et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Conventional cardiovascular risk factors such as high blood
pressure and high cholesterol do not account fully for
variation in coronary heart disease, suggesting additional
risk factors warrant investigation. A considerable amount
of evidence has shown that psychosocial factors play an
important role in the etiology and progression of certain
cardiovascular diseases such as atherosclerosis [1, 2]. Since
the challenge of quantifying and deﬁning the impact of stress
on human CVD poses diﬃculties, attempts have been made
to develop animal models to overcome these diﬃculties. In
landmarkstudies,Kaplanetal.showedthatstressintheform
of instable social hierarchies accelerated atherosclerosis in
male cynomolgus monkeys [3].
However, despite accumulating evidence and increased
awareness of the importance of stress in the pathogenesis of
atherosclerosis, the underlying mechanisms are still largely
unknown [4]. It is believed that the prolonged, multifaceted
neurohormonal activation seen during chronic exposure to
stress may be harmful for the cardiovascular system [5].
Though inﬂammatory response is contained within the
stress response, the exact mechanisms responsible for stress-
modulated inﬂammatory responses remain to be elucidated.
Accumulating evidence also indicates that atherosclerosis
is the result of a prolonged and excessive inﬂammatory
process in the vascular wall [6]. It is, therefore, important
to inquire whether stressful psychosocial factors can initiate
or participate in the inﬂammatory events that culminate in
atherosclerosis. In the present study, we examined the eﬀect
of CMS on the development of atherosclerosis in apoE-/-
mice, since this strain is very sensitive to the unpredictable
CMS protocol and develops atheroma similar in type and2 Journal of Biomedicine and Biotechnology
distribution to that found in human even when fed on
normal diet [7]. To investigate whether TLRs might be
involved in the eﬀect of CMS, we compare gene expression
in aortas of stressed and unstressed mice using TLRs
signaling pathway real-time PCR microarrays consisting of
87genes.
Evidence is accumulating that TLR4 plays an important
role in the pathogenesis of atherosclerosis and other diseases
[2, 8–10]. In the ﬁrst line of defence, TLR4 recognizes
pathogen-associated molecular patterns (PAMPs) and acti-
vates the inﬂammatory cell via the NF-κBp a t h w a y[ 11].
The expression of TLR4 has been detected in various types
of cells including T cells, monocytes, macrophages, and
dendritic cells. MyD88 was ﬁrst characterized as an essential
component for the activation of innate immunity by all
the TLRs [12]. Ligand binding to TLR4 results in the
recruitment of the adaptor molecule MyD88 to the Toll/IL-
1 receptor domain of the receptor. Intracellular propagation
of the signal leads to NF-κB activation and subsequent
induction of proinﬂammatory cytokines that have also been
demonstrated in inﬂammation after subacute stress [13,
14]. In addition, mediators that have been isolated after
stress have been identiﬁed as ligands for TLR4 [15]. Thus,
there is a plausible linkage of TLR4 to the production of
proinﬂammatory cytokines, which, in turn, contribute to
atherosclerosis. However, prior research has not conclusively
demonstrated a role for TLR4 in the onset of atherosclerosis
induced by CMS. Limited evidence for a role of TLR4
pathwayincardiovasculardiseaseinresponsetopsychosocial
stress comes from animal studies describing stress-induced
TLR4 signaling pathway activation and subsequent NF-
κB-dependent gene expression and neuroinﬂammation in
the brain cortex of mice exposed to immobilization stress
[16]. Therefore, TLR4-MyD88-NF-κB is a good candidate
signaling pathway to convert psychosocial stress into cardio-
vascular diseases.
The aim of the present study was to examine the eﬀect
of CMS on the development of atherosclerosis in adolescent
apoE-/- mice and investigate whether the TLR4 signaling
pathwayparticipates in the development ofatherosclerosis in
CMS mice. If this is true, it may provide an explanation for
the approximately 40% of patients with atherosclerosis who
have no other known risk factors [17].
2.Methods and Materials
2.1. Animals. One hundred twenty male apoE-/- mice (from
Peking University, China), 4 weeks old, weighing approx-
imately 16g upon arrival at the animal facilities, served
as subjects in the present study. They were kept in the
experimentalroomaweekbeforetheonsetoftheexperiment
in order to familiarize them with the testing environment.
A l lm i c ew e r eh o u s e dﬁ v ep e rs m a l lp o l y c a r b o n a t ec a g e( 8×
13.5×8.1cm)andmaintainedunderequivalentconditionsof
temperature (23±1◦C), a 12-hour light-dark cycle (lights on
at 7:00 AM and oﬀ at 7:00 PM), and relative humidity (55%
to 60%). Food and water were available ad libitum, except
before assessment of sucrose consumption. Mice were cared
inaccordancewiththeprinciplesandguidelinesoftheGuide
for the Care and Use of Laboratory Animals, China Council
on Animal Care. All animal procedures were approved by the
Animal Welfare Committee of University of south China.
2.2. Experimental Procedures
2.2.1. Sucrose Consumption. At the start of the experiment,
mice were ﬁrst trained to consume a 1% sucrose solution
[18]. Sucrose consumption and body weight were moni-
tored throughout the experiment. After a one-week period
of adaptation, sucrose solution intake baseline tests were
performed (two tests per 6 days) over a period of 12 days
for all subjects. This was done in order to familiarize mice
with the sucrose preference procedure. These tests involved
an 8-hour period of food and water deprivation, followed
by the oﬀering of a sucrose solution for 1 hour. Intake
was determined by weighing the bottles containing sucrose
solution at the beginning and at the end of each test. After
this phase (12 days), one group was housed under normal
conditions (control mice, n = 60) and the other group
(stressed mice, n = 60), was subjected to chronic mild stress.
2.2.2. Chronic Mild Stress Protocol. T h es t r e s ss c h e m ew a s
slightly modiﬁed from that previously used for mice by
Yalcin et al. [19] and consisted of the following: two periods
of continuous overnight illumination, two periods (7 and
17 hours) of 45 degrees cage tile, one 17-hour period
in a soiled cage (100mL water in sawdust bedding), two
periods (9 and 15 hours) of intermittent sound (a tone
of 80dB), three periods (7, 9, and 17 hours) of low-
intensity stroboscopic illumination (150ﬂashes/min), and
two periods of exposure to rat odour (removal of the cage
containing the experimental mice into the procedure room
and placing the experimental mice into cages in which
rats had been held). The stressed mice received this stress
protocol for 0 (n = 20), 4 (n = 20), and 12 weeks (n = 20).
Thecontrolmicewerehousedunderidenticalconditionsina
separate room and had no contact with the stressed animals.
2.2.3. Body Weight. Before and during the unpredictable
chronic mild stress, mice were weighted weekly from Week
0 (initial week) to Week 12 of the procedure every Monday.
2.2.4. Assessment of the Serum Corticosterone Concentration.
The corticosterone concentrations of mice were measured at
diﬀerentstagesoftheprocedure.24hoursafterthelasttestof
sucrose intake, between 9:00 and 10:00 AM, approximately
0.20mL of blood was drawn from the retro-orbital sinus.
Animals received an intraperitoneal (i.p) injection of sterile
isotonic saline (0.5mL) after each collection and then were
returned to their cages. Samples were centrifuged at 4◦Cf o r
30minutesat2500rpm.Serumcorticosteroneconcentration
was determined by solid-phase 125I radioimmunoassay using
a commercially available reagent, kit (Diagnostic Products,
Los Angeles, CA). The assay sensitivity was 16ng/mL, and
the intra- and interassay coeﬃcients of variation were 12.2%
and 14.9%, respectively.Journal of Biomedicine and Biotechnology 3
2.2.5. Analysis Lipid Proﬁle. TC, LDLc, and TG concen-
trations were measured enzymatically using commercially
available kits (abcam, ab65390). The assays were performed
in accordance with the manufacturer’s instructions.
2.2.6. Assessment of Atherosclerosis in Aortic Tree. Mice were
fed a high-fat, high-cholesterol (atherogenic) diet containing
5% (wt/wt) fat and 1.0% cholesterol from 5 weeks of age
through the duration of the experiment. After anesthe-
sia with pentobarbital sodium, the mice were perfusion-
ﬁxed with 4% paraformaldehyde, and their aortic trees
were removed including the brachiocephalic region, the
carotid, and femoral branches. Whole aortas were cleaned
of adventitia and opened longitudinally from the aortic arch
to the iliac bifurcation, mounted en face, and stained for
lipids with Soudan IV. Lesion areas were quantiﬁed with
IMAGEPRO PLUS (Media Cybernetics, Silver Spring, MD).
Image analysis was performed by a trained observer blinded
to the experiment. The percent of the aortic surface covered
by lesions was determined using an en face preparation.
2.2.7. Assessment of Atherosclerosis in Aortic Sinus. To deter-
mine cross-sectional lesion area, hearts were embedded in
OCT compound (Tissue Tek, Sakura, Torrance, CA), frozen
on dry ice, and then stored at −70◦C until sectioning. Serial
sections 6μm thick were collected on slides for immuno-
histochemistry and staining with Oil red O as described
earlier[20].C r osssectionsoftheaorticsin usandaorticval v e
were stained with Oil red O and counterstained with Gill
III hematoxylin (Sigma). Lesion areas were quantiﬁed with
IMAGEPRO PLUS (Media Cybnetics, Silver Spring, MD),
Results are expressed as the average lesion size per section
or as the percent of the total cross sectional vessel wall area
(normal plus diseased area/section, excluding the lumen)
stained with Oil red O. For each animal, the average of 12
sectionswasdetermined,anddataareexpressedaslesionsize
or mean percent lesion area ± SEM.
2.2.8. Immunohistochemistry. Frozen sections of apoE-/-
mice aortic root were ﬁxed with acetone for 5 minutes at
room temperature and then immunostained with Rabbit
antimouse TLR4 antibody (abcam, ab47093, 1 : 100)
according to the instructions on DAB immunostaining kit.
Rabbit IgG was used as a negative control.
2.2.9. Analysis of Gene Expression in Aorta Using Real-
Time PCR Arrays. TLRs signaling pathway real-time PCR
microarrays were purchased from SuperArray Bioscience
Corporation(Frederick,MD,USA,catalognumber:APMM-
018) and were used according to the manufacturer’s instruc-
tions. Brieﬂy, Total RNA (n = 5 mice per group) was
extracted from frozen aorta with TRIzol reagent (Invitrogen
Canada Inc, Burlington, Canada) according to the manufac-
turer’s protocol. Clean up of the RNA was carried out with
a Qiagen RNeasy Mini Kit (Qiagen, Valencia, CA). First-
strand cDNA was synthesized from 1.5μgo ft o t a lR N Ai n
aﬁ n a lv o l u m e2 0 μL using a Reaction Ready ﬁrst strand
cDNA synthesis kit (SuperArray Bioscience Corporation).
After incubation at 65◦C for 5 minutes and cooling down to
37◦C for 8 minutes, RT cocktail was added to the annealing
mixture and further incubated sequentially at 50◦Cf o r6 0
minutes, 70◦C for 15 minutes, then adding 91μL of ddH2O
to each 20μL of cDNA synthesis reaction, mixed well, and
holding the ﬁnished First Strand cDNA Synthesis Reaction
on ice until the next step or store overnight at −20◦C.
The 96-Well PCR Arrays were loaded with the following
cocktails: 1275μL2× SuperArray PCR mastermix, 102μL
diluted ﬁrst strand cDNA synthesis reaction, 1173μLo f
ddH2O. The Real-time PCR reaction (40 cycles) consisted of
sequential incubations for 10 minutes at 95◦C, 15 seconds
at 95◦C, and 1 minute at 60◦C. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) and β-actin were ampliﬁed from
allsamplesoneacharrayashousekeepinggenestonormalize
expression levels of targets between diﬀerent samples and
to monitor assay reproducibility. Threshold cycle numbers
(CT) were determined with BioRadi Cycler iQ Multicolor
Real-Time PCR Detection System (version 1.1 software) and
transformed using the ΔCT comparative method. Gene-
speciﬁc expression values were normalized to expression
values of GAPDH or β-actin (endogenous control) within
each sample. Relative quantiﬁcation was performed using
the comparative method. The amount of target, normalized
to an endogenous reference and relative to a calibrator, was
determined by the comparative Ct method (ΔΔCT). If the
fold change is greater than 1, then the result may be reported
as a fold upregulation. If the fold change is less than 1, then
the negative inverse of the result may be reported as a fold
downregulation.
2.2.10. Western Blotting. Aortas were excised from killed
mice, and then membranous proteins extracted were pre-
pared from pooled arteries. Equal amounts of extracted
proteins were separated by SDS-PAGE and transferred to
nitrocellulose membranes (BioRad, Hercules, PA, USA).
The primary antibodies used in this study were Rabbit
antimouseTLR4 antibody (abcam, ab47093, 1 : 1000) and
Rabbit antimouse NF-κB p65 (cell signaling technology,
3037, 1 : 1000). Immunodetection was accomplished using
appropriate horseradish peroxidase-linked secondary anti-
bodies (KPL, 074-1516) and enhanced chemiluminescence
system (KPL). The blots were exposed to ﬁlms (Fuji RX
FUJIFILM, Tokyo, Japan). Protein levels were quantiﬁed by
scanning densitometry using image-analysis systems.
2.2.11. Detection of MCP-1, sICAM-1, IL-1β,a n dT N F - α
Production. The serum concentrations of MCP-1, sICAM-1,
IL-1β,a n dT N F - α were measured utilizing a high-sensitivity
enzyme-linked immunosorbent assay (R&D Systems, Inc)
according to the manufacturer’s instructions. The mini-
mum detectable concentrations were <0.1pg/mL for TNF-a,
<3pg/mLforIL-1β, <2.2pg/mL for MCP-1, and 10pg/mL
for sICAM.
2.3. Statistical Analysis. The results were presented as
mean ± SEM. The data were analyzed by two-way analysis of4 Journal of Biomedicine and Biotechnology
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Figure 1: 1% sucrose solution preference in CMS and control
groups (n = 20 per group) following diﬀerent weeks of CMS.
Sucrose intake was signiﬁcantly reduced in the CMS group com-
paredwiththecorrespondingcontrolgroup.Therewasasigniﬁcant
stress × week interaction on sucrose intake (n = 20, P<. 001 by
ANOVA). An ANOVA performed on sucrose intake yielded a main
eﬀect of group (P<. 001). Values are means ± SEM. ∗P <. 05, ∗∗P
<. 01, ∗∗∗P <. 001 versus respective CMS value.
variance (ANOVA) with bonferroni correction and Student’s
t-test. Statistical signiﬁcance was accepted when P<. 05.
3. Results
3.1. Sucrose Preference Tests. CMS induced a decrease in
sucrose intake, relative to control conditions, which is
indicative of operationally deﬁned anhedonia. As shown in
Figure 1, there was no baseline diﬀerence in sucrose intake
between the two groups (P>. 05). The control group did
not show a signiﬁcant diﬀerence in the consumption of the
sucrose solution over a 12-week period. However, the CMS
group gradually reduced the consumption of the sucrose
solution from the second week to the twelfth week. Two-way
ANOVAwasperformedonsucroseintake.Asexpected,there
was a signiﬁcant stress × week interaction on sucrose intake
(F(12,456) = 141.42, P<. 001). A signiﬁcant decrease in
sucrose intake was observed in stress animals in comparison
to controls, starting from the second week CMS (t(38) =
12.71,P<. 05) and persisted during the third week (t(38) =
18.32,P<. 05). There was a more signiﬁcant decrease from
the fourth week (t(38) = 27.68,P<. 01) until the twelfth
week (t(38) = 36.62,P<. 001). An ANOVA performed on
sucrose intake yielded a main eﬀect of group (F(1,456) =
236.47,P<. 01).
3.2. Body Weight. Body weight was statistically compared
in both stressed and nonstressed mice with a mixed-design
ANOVA.Asexpected,therewasamaineﬀectofBodyweights
increased over time in both CMS and control mice, but
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Figure 2: Body weight (in grams) in CMS and control groups
during the CMS period (n = 20 per group). All mice were weighted
weeklyfromWeek0(initialweek)toWeek12oftheprocedureevery
Monday following 12-hour period of food and water deprivation.
Values are means ± SEM. ∗P <. 05 versus the stressed group.
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Figure 3: Serum corticosterone levels in CMS and control groups
followingatdiﬀerent weeks of CMS (n = 20 pergroup).Serum cor-
ticosterone concentrations were assayed using a radioimmunoassay
(RIA). Corticosterone levels were higher in the CMS group versus
the control group. Data are mean ± SEM. ∗P <. 05, ∗∗P<. 05, ∗∗∗P
<. 001 versus respective control value.
CMS mice weighed markedly less than the controls from
week 3 until the end of experiment (P<. 05), although the
diﬀerence between the two groups was reduced after 4 weeks
of repeated CMS. However, body weight gains of CMS mice
remained similar to those of the control mice from week 5 to
week 10, and thereafter the diﬀerence began to be reduced.Journal of Biomedicine and Biotechnology 5
MeanbodyweightsofCMSandcontrolgroupsarepresented
in Figure 2.
3.3. Serum Corticosterone Concentration. Corticosterone
concentration was signiﬁcantly higher in the CMS group
than that in the control group (Figure 3). Serum corticos-
terone levels in all control animals were less than 100ng/mL,
but there was a great increase in serum corticosterone in
stressed mice at diﬀerent stage. The degree of increase in
corticosterone concentration was related to the duration
of stress such that there was an 11-fold increase in those
mice exposed to 12 weeks of stress compared with controls
(457.3 ±56.5ng/mL versus 40.2 ±7.2ng/mL).
3.4. Eﬀect of CMS on the Lipid Proﬁle of ApoE-/- Mice. Mean
plasma total cholesterol (TC), triglyceride (TG), and low-
density cholesterol (LDLc) levels were signiﬁcantly elevated
in apoE-/- mice exposed to CMS for 12 weeks (Table 1,
P<. 05), compared with control mice. Whereas plasma
high-density cholesterol (HDLc) level in CMS was markedly
lower than that in control mice (164.3 ± 15.8mg/dL versus
293.8 ±31.2mg/dL).
3.5. CMS Eﬀects on Aortic Atherosclerosis in ApoE-/- Mice.
Exposure to CMS resulted in a signiﬁcant increase in
atherosclerotic lesions area in entire aortic trees of apoE-/-
mice. The contribution of CMS to atherosclerosis at diﬀerent
stages of lesion development was studied in apoE-/- mice.
As shown in Figure 4, Soudan IV staining was absent
in the normal vessels obtained from control and CMS
apoE-/- mice at 0 week (Figure 4(a).(A)). Whereas 4 weeks
(Figure 4(a).(B)) or 12 weeks (Figure 4(a).(C)) later, lesions
were observed throughout the aorta in both two groups, and
lesions were more extensive in stressed mice compared with
control mice. As shown in Figure 4(b), measurement of total
aortic atherosclerotic lesion area by en face lipid staining
revealed an increase by 121.14±18.2% and 106.58±14.43%
aortas of mice exposured to CMS for 4, 12 weeks versus
corresponding control mice, respectively, but no diﬀerence
i ne nf a c el e s i o na r e aw a sd e t e c t e db e f o r em i c ee x p o s u r e dt o
CMS (at 0 week).
3.6. CMS Eﬀects on Aortic Sinus Atherosclerotic Lesion in
ApoE-/- Mice. As shown in Figure 5(a)((A)–(F)), character-
ization of aortic sinus atherosclerotic lesions in CMS apoE-/-
mice revealed a markedly increase in intimal thickening in
all three subvalvular sectors, caused by increases in cellular
and extracellular matrix elements within the intima. After
12 weeks fed on the atherogenic diet, the mean lesion area
was 0.24 ± 0.03mm2 in the stressed group; meanwhile the
atherosclerotic lesion was only 0.05 ± 0.01mm2 (P<. 01)
in the control group (Figure 5(b)). Furthermore, area of
atheroma in aortic sinus increased linearly in response to
duration of CMS exposure such that mice exposed to 12
weeks of stress had 3 times more atheroma than control
mice (Figure 5(c),2 4 .16 ± 3.85% versus 6.35 ± 1.62%, P<
.01), which indicated progression of atherosclerotic plaque
formation in the stressed group.
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Figure 4: CMS markedly increases the extent of aortic atheroscle-
rosis development in apoE-/- mice. (A)–(C) Representative pho-
tographs of aortic sinuses from control apoE-/- (top) and CMS
(bottom) apoE-/- mice. (a) Aortas of apoE-/- mice subjected
to CMS or normal condition (control) for 0 week (A), 4
weeks (B), and 12 weeks (C) were isolated and stained for
lipid deposition Soudan IV. Representative specimens from the
two groups are shown. (b) Quantiﬁcation of plaque areas in
whole aortas in CMS and control apoE-/- mice stained for
lipid deposition with Soudan IV. Each bar represents mean ±
SEM (n = 10 per group). Total plaque area in CMS mice
was signiﬁcantly increased compared with corresponding con-
trol mice. ∗∗P <. 01, ∗∗∗P <. 001 versus the control
group.6 Journal of Biomedicine and Biotechnology
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Figure 5: CMS markedly increases the extent of atherosclerosis development in aortic sinus of apoE-/- mice. (A)–(F) Representative
photographs of aortic sinuses from control apoE-/- (top) and CMS (bottom) apoE-/- mice. 6μmf r o z e ns e c t i o n so fa p o E - / -m i c es u b j e c t e d
to CMS or normal condition (control) for 0 week (A), (D), 4 weeks (B), (E), 12 weeks (C), (F) were stained with H&E (A)–(C) and oil red O
(D)–(F), respectively. (b), (c) Quantiﬁcation of plaque areas in aortic sinuses in CMS and control apoE-/- mice stained for lipid deposition
with oil red O. Each bar represents mean ± SEM (n = 10 per group). Total plaque area in CMS mice was signiﬁcantly increased compared
with corresponding control mice. ∗∗P <. 01, ∗∗∗P <. 001 versus the control group. (Magniﬁcation × 100).Journal of Biomedicine and Biotechnology 7
3.7. Real-Time PCR Array Analysis of CMS Induced Gene
Expression of TLRs Signaling Pathway. In this study, we ﬁrst
compared the gene expression pattern of TLRs signaling
pathway in aorta of mice either exposed or not exposed to
CMS. ApoE-/- mice aged 4 weeks were subjected to diﬀerent
durations of CMS, and aorta were harvested for total RNA
isolation and subsequent Real-time PCR Array analysis.
Genes with more than a twofold increase or decrease in
their expression were considered signiﬁcant in the selection
criteria. To ensure that our data were reliable, we used
ﬁve arrays per animal group. 43 of the 87 genes showed
diﬀerential expression in the stressed mice when compared
to the unstressed animals (Table 2(b)). Additionally, the
changes in relative expression of some of these genes were
veriﬁed by western blotting. We found that 15 genes were
upregulated whereas 28 genes were downregulated. Because
real-timePCRmicroarraysmeasurechangesinmRNAlevels,
which may not always correlate with protein expression,
we also assessed the diﬀerentially expressed genes for the
TLR4receptorandNF-kBbywesternblotting,IL-1β,TNF-α,
MCP-1, and sICAM-1 by ELISA analysis.
3.8. Eﬀect of CMS on TLR4 and NF-κBE x p r e s s i o n si nA o r t a
of ApoE-/- Mice. Western blotting with an Ab against TLR4
and NF-κB showed reactive protein bands at the size of
TLR4 (73kDa) and NF-κB p65 (80kDa) in aortas of chronic
mild stress and control groups following diﬀerent weeks
of CMS. As demonstrated in Figure 6, TLR4 and NF-κB
protein levels in mice subjected to 4 and 12 weeks chronic
mild stress were more abundant compared with that in
the corresponding control group mice, consistent with the
mRNA pattern (Table 2(a)). Thus, both protein and mRNA
of TLR4 and NF-κB p65 were more abundant in CMS mice
than that in control mice, respectively (P<. 05, P<. 01).
In Figure 6(b(1)) a mean relative intensity of TLR4 in CMS
mice was stronger than that in control mice (P<. 05, P<
.01).
3.9. The Expression of TLR4 Was Upregulated in Atheroscle-
rotic Lesions of the Stressed ApoE-/- Mice. As shown in
Figure 7, there is only minimal immunoreactivity to TLR4
in nonatherosclerotic aortic sinus of apoE-/- mouse. TLR4
immunoreactivity was markedly observed in the aortic
root atherosclerotic lesions, and TLR4 expression (brown
staining) observed around the lipid core and at the shoulder
of lipid-rich plaques of mice subjected to CMS for 4 and 12
weeks was much stronger than that of control mice at the
same stage. Rabbit IgG staining was negative, indicating the
speciﬁc nature of the TLR4 immunostaining.
3.10. ELISA Analysis of Cytokines. The results showed that
the mean secretion of cytokine IL-1β in the stressed group
was signiﬁcantly higher than that in the corresponding
control group after fed an atherogenic diet for 4 and 12
weeks, respectively (Figure 8). MCP-1, sICAM-1, and TNF-
a levels in the serum of apoE-/- mice were also measured,
as shown in Figure 8; similar results could be collected for
the secretion of those cytokines compared with controls.
The secretion levels for those cytokines between the normal
control and the stressed group had signiﬁcant diﬀerence.
4. Discussion
ThemajorﬁndinginthisstudywasthatexposuretoCMSdid
inﬂuence atherosclerosisin apoE-/- mice. Importantly, in the
present study, we found that CMS mice showed a signiﬁcant
increase in gene expression of TLR4 pathway compared with
age-matched control mice. Our CMS-protocol was proven
eﬀectiveinmarkedlyincreasingtheserumcorticosteronelev-
els and decreasing the consumption of the sucrose solution.
Inthepresentstudy,concomitantwithlesionprogression
inCMSapoE-/-mice,wedemonstratedamarkedlyincreased
in the expression of TLR4, MyD88, and NF-kB mRNA in
the arterial lesions of these mice. Interestingly, the increased
expression of TLR4 mRNA was speciﬁc, while the expression
of the other 8 TLRs was either downregulated or unchanged
in the CMS model. This result indicates that a diﬀerential
physiological regulation of the several members of the TLRs
familyoccurs.Inthisstudy,wewereparticularlyinterestedin
TLR4 signal transduction, because the gene plays an impor-
tant role in the development of atherosclerosis and involves
in restraint stress-mediated immune alterations [8–10, 21].
We also found that mice exposed to CMS showed great
increases in atherosclerosis lesions compared with control
ones. Our ﬁndings are consistent with Kumari’s results [22].
To demonstrate that at this local level the TLR4-MyD88-NF-
kB signaling pathway is functional, we investigated MCP-1,
TNF-α,I L - 1 β, and sICAM-1 levels in the serum of apoE-
/- mice, since these are known to be produced through the
TLR4-MyD88-NF-kB-dependent pathway [23]. We found
that all four were signiﬁcantly increased in CMS mice,
consistent with the expression of TLR4, MyD88, and NF-kB.
Therefore, these data demonstrated that CMS at least partly
caused system inﬂammation and exacerbated atherogenesis
by activation of TLR4 signaling pathway.
Recently, the TLR4-MyD88-NF-kB pathway has been
suggestedasalinkbetweeninﬂammationandatherosclerosis
[24]. TLR4 is a key signaling receptor of innate immunity
because it senses the presence infectious agents and initiates
a proinﬂammatory signaling cascade. After binding to the
ligand, TLR4 engages a downsream cascade of signaling
molecules, including the adaptor MyD88, leading to the
activation of two distinct signaling pathways and ﬁnally
to the activation of two distinct signaling pathways. The
activation of NF-kB leads to the synthesis of a number
of proinﬂammatory mediators. Particularly, the chemokines
IL-1β,T N F - α, IL-6, ICMA-1, and MCP-1 were highly
upregulated after exposure to chronic mild stress [14]. These
chemokines are chemoattractants of monocytes and T cells,
which have been described in association with atheroscle-
rotic disease [25]. In this study, we found a considerable
monocytes and lymphocytes under the vascular adventitia
of CMS mice. These data suggested that stress-induced
high leveles of MCP-1 and ICAM-1 might play important
roles in early atherogenesis in CMS mice. Proliferation and
migration of smooth muscle cells (SMCs) are considered an8 Journal of Biomedicine and Biotechnology
Table 1: Eﬀect of CMS on plasma lipid levels of apoE-/- mice (mg/dL). Plasma lipid proﬁles in stressed and control mice were detected
following 12-hour period of food and water deprivation at the week 12 (n=20 per group). Data are mean ± SEM.
0 week 4 weeks 12 weeks
Control CMS Control CMS Control CMS
TC 461.33 ±40.61 474.68 ±42.23 1061.83 ±92.37 1471.42 ±163.23∗ 1582.66 ±181.21 2016.33 ±242.71∗
TG 78.52 ±4.74 80.27 ±3.61 125.22 ±16.74 211.56 ±26.22∗ 216.48 ±22.51 386.27 ±52.72∗
HDLc 69.26 ±2.63 71.81 ±4.26 186.38 ±30.11 235.12 ±22.72∗ 293.83 ±31.26 164.36 ±15.87∗
LDLc 313.61 ±34.22 322.62 ±30.66 750.39 ±81.23 1024.84 ±142.47∗ 1072.42 ±136.94 1465.83 ±164.46∗
∗ P<.05 versus the control group value.
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Figure 6: Validation of changes in TLR-4 (73KD) and NF-κB p65 (80kDa) protein expression by western blotting. Proteins extracted
were prepared from arteries (n = 6) of mice subjected to CMS or normal conditions for 0, 4, and 12 weeks, respectively. Each lane shows
representative western blots using anti-TLR4 or NF-κB p65 and anti-GAPDH bodies in (a1) and (a2), respectively. Each panel summarizes
densitometric readings of band intensities normalized to GAPDH, which was measured by densitometry with Image J image analysis
software. (b1), (b2) densitometric measurements TLR4 and NF-κB p65 from Western blots, respectively. Data are mean ± SEM. C: control
group; S: chronic mild stress group (n = 6 per group). ∗P <. 05, ∗∗P <. 01 compared with the control. The data are representative of three
experiments.
important event in the development of atherosclerosis. A
number of the cytokines that we observed to be upregulated
in adventitial ﬁbroblasts after TLR4 activation (IL-1β,I L -
6) inﬂuence smooth muscle proliferation and/or migration
[26]. Our results demonstrated that CMS induced by the
production of these cytokines might not be through p38
and JNK pathway but through the NF-kB pathway, since the
result has been demonstrated by evidence that Jun, Fos, and
MAPK mRNA expressions were markedly downregulated,
while MyD88 and Rela mRNA were greatly upregulated.
These data implied involvement of the TLR4-MyD88-NF-
kB-dependent pathway in the CMS-induced atherosclerosis
in apoE-/- mice.
Michelsen et al. [27] reported that Lack of TLR4 or
MyD88 reduced atherosclerosis and alters plaque phenotype
in apoE-/- mice. Our previous studies also showed that
Epigallocatechin-3-gallate,whichisablockingagentofTLR4
pathway, inhibited the development of atherosclerosis in
apoE-/- mice eﬀectively. Caso et al. found that TLR4 was
involved in the inﬂammatory response after subacute stressJournal of Biomedicine and Biotechnology 9
Table 2: CMS alters TLRs signaling pathway gene expression proﬁle in aortas of apoE-/- mice. ApoE-/- mice 4 weeks old were subjected to a
24-hour CMS daily for 0, 4, 12 weeks. Mice were sacriﬁced, and aortas were harvested. Total RNA was extracted, and microarray analysis was
determined as described under “materials and methods.” TLRs signaling pathway array consisting of 87 were used to analyze gene expression
in aorta from mice with or without chronic mild stress. The microarrays were used according to the manufacturer’s instructions. The table
showed gene expression changes ≥2.0-fold versus control. Calculate the fold change for each gene from control group to stress group as
2-ΔΔCt. Among 87 genes analyzed, 15 genes were upregulated, and 28 genes were downregulated by CMS.
(a) Genes upregulated in aorta of mice exposure to CMS compared with control mice (n = 5)
Well Symbol Description Fold increase P-value
A03 Ccl2 Chemokine (C-C motif) ligand 2 5.3 .02
A04 Cd14 CD14 antigen 2.4 .013
A09 Clec4e C-type lectin domain family 4, member e 3.88 .026
A10 Csf2 Colony stimulating factor 2
(granulocyte-macrophage)
2.06 .018
C03 Il1b Interleukin 1 beta 11.67 .008
C06 Il6 Interleukin 6 3.54 .018
C08 Irak1 Interleukin-1 receptor-associated kinase 1 2.78 .016
D12 Myd88 Myeloid diﬀerentiation primary response
gene 88
3.62 .032
E04 Nfkbib
Nuclear factor of kappa light chain gene
enhancer in B-cells inhibitor, beta 2.61 .041
E05 Nfkbil1 Nuclear factor of kappa light polypeptide
gene enhancer in B-cells inhibitor-like 1
3.35 .035
E09 Pglyrp1 Peptidoglycan recognition protein 1 5.84 .011
F02 Rela V-rel reticuloendotheliosis viral oncogene
homolog A (avian)
2.17 .031
F11 Tlr4 Toll-like receptor 4 4.04 .014
G05 Tnf T u m o rn e c r o s i sf a c t o r 2.15 .018
H03 Hsp90ab1 Heat shock protein 90kDa alpha (cytosolic),
class B member 1
2.05 .012
(b) Genes downregulated in aorta of mice exposure to CMS compared with control mice (n = 5)
Well Symbol Description Fold decrease P-value
A01 Btk Bruton agammaglobulinemia tyrosine
kinase
−3.13 .011
A02 Casp8 Caspase 8 −2.26 .024
A11 Csf3 Colony stimulating factor 3 (granulocyte) −8.03 .032
B01 Elk1 ELK1, member of ETS oncogene family −2.47 .021
B03 Fos FBJ osteosarcoma oncogene −2.06 .013
C01 Il12a Interleukin 12A −2.67 .028
C07 Il6ra Interleukin 6 receptor, alpha −2.9 .022
C09 Irak2 Interleukin-1 receptor-associated kinase 2 −2.08 .037
C11 Irf3 Interferon regulatory factor 3 −4.33 .019
C12 Jun Jun oncogene −2.06 .042
D01 Lta Lymphotoxin A −13.13 .011
D02 Muc13 Mucin 13, epithelial transmembrane −2.12 .016
D10 Mapk8ip3 Mitogen-activated protein kinase 8
interacting protein 3
−6.89 .02710 Journal of Biomedicine and Biotechnology
(b) Continued.
Well Symbol Description Fold decrease P-value
E02 Nfkb2 Nuclear factor of kappa light polypeptide
gene enhancer in B-cells
−2.06 .036
E06 Nfrkb Nuclear factor related to kappa B binding
protein
−4.94 .012
E07 Nr2C2 Nuclear receptor subfamily 2, group C,
member 2
−3.24 .028
E08 Peli1 Pellino 1 −2.45 .023
F01 Mapk8 Mitogen-activated protein kinase 8 −2.34 .026
F05 Ticam1 Toll-like receptor adaptor molecule 1 −24.17 .003
F06 Ticam2 Toll-like receptor adaptor molecule 2 −2.4 .044
F08 Tlr1 Toll-like receptor 2 −2.05 .032
F12 Tlr5 Toll-like receptor 5 −6.57 .026
G04 Tlr9 Toll-like receptor 9 −5.37 .022
G06 Tnfaip3
Tumor necrosis factor, alpha-induced
protein 3 −4.81 .023
G10 Traf6 Tnf receptor-associated factor 6 −2.52 .034
G11 Ube2n Ubiquitin-conjugating enzyme E2N −2.39 .028
H04 Gapdh Glyceraldehyde-3-phosphate dehydrogenase −3.26 .032
H05 Actb Actin, beta, cytoplasmic −2.63 .025
CMS
Control
(a) (b) (c) (d)
Figure 7: (a)–(c) Immunohistochemical evidence for TLR-4 expression within atherosclerotic plaque of aortic sinuses from control
apoE-/- (top) and CMS (bottom) apoE-/- mice. 5μm frozen sections of the apoE-deﬁcient mouse aortic root were ﬁxed with
acetone for 5 minutes at room temperature and then immunostained with Rabbit antimouseTLR4 antibody (1 : 100). Rabbit
IgG was used as a negative control. (a)–(c) represent TLR-4 expression within aortic sinus of apoE-/- mice exposed to normal
condition (control) or CMS for 0 week, 4, and 12 weeks, respectively (brown staining); (d) represents rabbit IgG staining for negative
control. In (a) there is minimal immunoreactivity to TLR-4 in nonatherosclerotic aortic sinus of apoE-/- mouse (magniﬁcation ×
400).Journal of Biomedicine and Biotechnology 11
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Figure 8: MCP-1, sICAM-1, and TNF-a levels in the serum of apoE-/- mice were analyzed by ELISA. IL-1β (a), TNF-a (b), sICAM-1 (c),
and MCP-1 (d) levels markedly increased in the serum of apoE mice following diﬀerent weeks of CMS compared with the corresponding
control group (n = 20 per group). These cytokines were measured by ELISA according to the manufacturer’s instructions. Data are mean ±
SEM. ∗P <. 05, ∗∗P <. 01, ∗∗∗P <. 01 versus respective control value.
[14]. Therefore, there is evidence supporting the impor-
tance of TLR4 signaling pathway-induced proinﬂammatory
cytokins in atherosclerosis in CMS mice.
Evidence suggests that not only exogenous but also
endogenous ligands [28] can activate TLR4. As endogenous
ligands can also trigger TLR4, it is possible that this receptor
plays a role in atherosclerotic lesion development in the
absence of pathogens. These endogenous ligands for TLR4
are mostly produced during stress, such as heat shock
proteins (HSPs), oxLDL, and EDA domain of ﬁbronectin. It
hasbeendemonstratedrecentlythatoxLDLandHSPsupreg-
ulate the expression of proinfammatory cytokines through
activation of TLRs, and a wide variety of stressful stimuli
can increase the intracellular synthesis of these proteins.
Moreover, there is evidence that both glucocorticoids and
catecholaminescontributetoHSPsresponseinpsychological
stress situations [29]. Our data revealed that HSP90 mRNA
expression was greatly increased in CMS mice. Furthermore,
our previous study demonstrated that basal TLR-4 mRNA
expression in human monocyte-derived macrophages was
upregulated by ox-LDL and HSP90 in vitro. Together,
these data suggested that CMS-induced HSP90 acted as
an endogenous ligand for TLR4 to activate TLR4 signaling
pathway. These ﬁndings perhaps can explain a signiﬁcant
increase in gene expression of TLR4 pathway and higher
inﬂammatory response found in CMS mice.
Plasma corticosterone levels are very sensitive to rapid
release of corticosterone due to handling stress. Our serum12 Journal of Biomedicine and Biotechnology
corticosterone data are consistent with Kumari’s results
showing that CMS induced a marked (10-fold) increase
in corticosterone levels in plasma [21]. Elevation of cor-
ticosterone, which induced by stress, would contribute to
endothelial damage, recruitment, endothelial adhesion, and
perhaps transmigration of inﬂammatory cells, especially
monocytes. Elevated corticosterone can induce an athero-
genic lipid proﬁle similar to the dyslipidemia that may be
present in patients with atherosclerosis [30]. Recruitment of
monocytes which adhere to and permeate the arterial wall is
one of the earliest steps in the progression of atherosclerosis.
We also found that CMS produced the more aggravated
atherogenic lipid proﬁle. We consider now the important
changes in lipid metabolism that occur with stress due,
in large part, to the stress hormones. Thus, it appears
that a marked increase in plasma corticosterone levels can
accelerate atherosclerosis.
In summary, the present study raises the possibility that
TLR4-MyD88-NF-κB pathway may play a critical role in
CMS-inducedprolongedandexcessiveinﬂammatoryprocess
in the vascular wall that culminated in atherosclerosis. Sig-
niﬁcantly, genes in the TLRs signaling pathway we detected
as regulated in CMS-induced atherosclerosis in apoE-/- mice
have not been reported by others so far. Our results of
this study should motivate future studies using TLR4/apoE
double knockout mice to test to what degree CMS is linked
with development of atherosclerosis.
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